Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Biocon Ltd.
NSE: BIOCON
|
BSE: 532523
|
ISIN: INE376G01013
|
Industry: Biotechnology
US FDA Observation
|
Mid-range Performer
347.6500
-1.75
(
-0.50
%)
NSE
Oct 14, 2025
12:50 PM
Volume:
2.0M
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Biocon Ltd.
17 Jan 2024
US FDA Observation
347.65
-0.50%
Biocon
Buy:
Biocon Ltd.
by
Sharekhan
Target: 332
Recommendation
Target
Sharekhan
Promoters have decreased holdings from 60.64% to 54.45% in Jun 2025 qtr
More from Biocon Ltd.
Recommended
Market trades lower, Emirates NBD Bank to acquire 51% stake in RBL Bank for ~Rs 15,000 cr
Trendlyne Marketwatch |
14 Oct 2025, 12:21PM
IPO market cools: LG Electronics, Canara Robeco, plus seven listings, and a new issue
|
13 Oct 2025, 04:01PM
A long drawn out R&D plan may be finally paying off for Biocon
|
20 Aug 2020